Precision Medicine Leaps Ahead with Data Science: Bio-IT World 2020 to Highlight Data-Driven Approaches to Discovery

Posted Feb 04, 2020

3,200 Life Science and IT Leaders to Unite for Conference and Expo, April 21-23 in Boston

BOSTON--February 4, 2020--Bio-IT World 2020, the leading conference and expo uniting life science, data, informatics and IT leaders, today announced an expanded focus on the Data Science innovations that are moving precision medicine into new frontiers.

More than 3,200 such experts from pharmaceutical, biotech, healthcare and technology organizations, government and academia will converge for the 19th annual event, taking place April 21-23, 2020 in Boston.

“Data science is foundational to life science companies—changing the competencies required to compete. The opportunities to push our industry to the edge of discovery are thrilling for those organizations that embrace a collaborative, data-driven approach,” said Allison Proffitt, Editorial Director, Bio-IT World.

From a plenary keynote presentation on the National Institutes of Health’s (NIH) Strategic Vision for Data Science, to a new Data Science and Analytics Technologies track with Bristol-Myers Squibb, Takeda and more, the conference will highlight effective strategies, analytics and tools.

Altogether, 16 conference tracks will cover AI for Drug Discovery, Bioinformatics, Data Storage and Transport, Pharmaceutical R&D Informatics, Cancer Informatics, Genome Informatics, Clinical Research and Translational Informatics, Data and Metadata Management, Data Visualization Tools, Emerging AI Technologies, AI: Business Value Outcomes, Software Applications and Services, Data Security and Compliance, Cloud Computing, and Open Access and Collaborations, in addition to Data Science and Analytics Technologies.

Other highlights include 250+ presentations, 160+ exhibitorsPlenary Keynotespre-conference workshops, a Hackathonawardsposter sessions and networking. See details at

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharma Week, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT WorldClinical Research News and Diagnostics World.


Contact Dawn Ringel

781-449-8456 or [email protected]